Pharmaceutical company sponsorship of diagnostic testing remains an area with a gaping divide between the views of regulators and industry, ...

A recently identified bacterial protein structure is contributing to the design of novel anticancer drug delivery systems.

BB-1701 has survived Eisai’s decision not to option the HER2-directed antibody-drug conjugate. | BB-1701 has survived Eisai’s ...

Early diagnosis and treatment of active Tuberculosis is utmost priority, but identifying the latent TB, especially among the ...

Although Eisai decided not to option a HER2-targeted drug under a deal with BlissBio, Angle wants to keep working with the firms to advance its CTC technology.

Pancreatic cancer is another disease that could benefit from a blood-based diagnostic test. Unlike colon cancer, pancreatic ...

Highlights The HHS-OIG released a favorable opinion regarding free drugs offered to patients in financial need for a drug ...

OsteoStrong, a global leader in skeletal strength conditioning, is expanding with a new location in Gothenburg, Sweden, offering residents a cutting-edge, drug-free solution to enhance bone density, ...

Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, published positive results from the VERIFI clinical validation of its next-generation test for pancreatic cancer on ...

Recovery advocates have been pushing for years to get a bill passed to decriminalize test strips, which allow users to ...